IceCure Medical (ICCM) Equity Average (2021 - 2025)
IceCure Medical (ICCM) has disclosed Equity Average for 5 consecutive years, with $8.0 million as the latest value for Q4 2025.
- Quarterly Equity Average fell 16.32% to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Dec 2025, down 16.32% year-over-year, with the annual reading at $8.0 million for FY2025, 16.32% down from the prior year.
- Equity Average for Q4 2025 was $8.0 million at IceCure Medical, down from $9.5 million in the prior quarter.
- The five-year high for Equity Average was $26.2 million in Q4 2022, with the low at $8.0 million in Q4 2025.
- Average Equity Average over 5 years is $15.8 million, with a median of $16.3 million recorded in 2021.
- The sharpest move saw Equity Average skyrocketed 60.65% in 2022, then plummeted 49.28% in 2024.
- Over 5 years, Equity Average stood at $16.3 million in 2021, then soared by 60.65% to $26.2 million in 2022, then dropped by 28.25% to $18.8 million in 2023, then crashed by 49.28% to $9.5 million in 2024, then dropped by 16.32% to $8.0 million in 2025.
- According to Business Quant data, Equity Average over the past three periods came in at $8.0 million, $9.5 million, and $18.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.